EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY – Get Free Report) was the recipient of a significant increase in short interest during the month of December. As of December 31st, there was short interest totaling 7,240 shares, an increase of 45.5% from the December 15th total of 4,976 shares. Based on an average daily volume of 84,430 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the shares of the stock are short sold. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily volume of 84,430 shares, the short-interest ratio is presently 0.1 days.
Analyst Ratings Changes
A number of equities analysts recently weighed in on the company. UBS Group raised EssilorLuxottica from a “hold” rating to a “strong-buy” rating in a report on Thursday, November 27th. Hsbc Global Res raised shares of EssilorLuxottica to a “strong-buy” rating in a research note on Wednesday. Kepler Capital Markets raised shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a research note on Thursday. The Goldman Sachs Group reaffirmed a “buy” rating on shares of EssilorLuxottica in a report on Friday, December 5th. Finally, Royal Bank Of Canada reissued an “outperform” rating on shares of EssilorLuxottica in a research note on Tuesday, October 28th. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Buy”.
View Our Latest Analysis on ESLOY
EssilorLuxottica Price Performance
EssilorLuxottica Company Profile
EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.
The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.
Read More
- Five stocks we like better than EssilorLuxottica
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
- Wall Street Alert: Buy AES
Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.
